We feel like a SITTING DUCK on the markets.
“It’s waiting that helps you as an investor, and a lot of people just can’t stand to wait.” – Charlie Munger
Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.
Gain over the quarter: +32 %
Fair value: £ 35.50
Average yearly return: 48%